Sonendo (NYSE:SONX – Get Free Report) is one of 14 public companies in the “Dental equipment & supplies” industry, but how does it weigh in compared to its competitors? We will compare Sonendo to similar businesses based on the strength of its analyst recommendations, institutional ownership, valuation, profitability, dividends, risk and earnings.
Valuation & Earnings
This table compares Sonendo and its competitors top-line revenue, earnings per share (EPS) and valuation.
Gross Revenue | Net Income | Price/Earnings Ratio | |
Sonendo | $44.40 million | -$60.92 million | -0.14 |
Sonendo Competitors | $1.43 billion | -$41.50 million | 0.90 |
Sonendo’s competitors have higher revenue and earnings than Sonendo. Sonendo is trading at a lower price-to-earnings ratio than its competitors, indicating that it is currently more affordable than other companies in its industry.
Risk and Volatility
Analyst Recommendations
This is a summary of recent ratings and recommmendations for Sonendo and its competitors, as provided by MarketBeat.com.
Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score | |
Sonendo | 0 | 3 | 1 | 0 | 2.25 |
Sonendo Competitors | 126 | 236 | 295 | 0 | 2.26 |
Sonendo presently has a consensus price target of $1.88, suggesting a potential upside of 1,938.04%. As a group, “Dental equipment & supplies” companies have a potential upside of 147.74%. Given Sonendo’s higher possible upside, equities analysts clearly believe Sonendo is more favorable than its competitors.
Profitability
This table compares Sonendo and its competitors’ net margins, return on equity and return on assets.
Net Margins | Return on Equity | Return on Assets | |
Sonendo | -138.88% | -121.92% | -58.04% |
Sonendo Competitors | -38.90% | -107.47% | -16.13% |
Insider and Institutional Ownership
28.7% of Sonendo shares are owned by institutional investors. Comparatively, 38.9% of shares of all “Dental equipment & supplies” companies are owned by institutional investors. 6.4% of Sonendo shares are owned by company insiders. Comparatively, 23.6% of shares of all “Dental equipment & supplies” companies are owned by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock will outperform the market over the long term.
Summary
Sonendo competitors beat Sonendo on 10 of the 12 factors compared.
Sonendo Company Profile
Sonendo, Inc., a commercial-stage medical technology company, develops, manufactures, and commercializes devices for root canal therapy in the United States and Canada. It provides GentleWave, a tooth decay treatment, a technology platform designed for cleaning and disinfecting the microscopic spaces within teeth without the need to remove tooth structure. The company also offers SoundSeal, a material used to build and create a sealing platform on the top of the crown; and Sonendo-branded liquid solution of ethylenediaminetetraacetic acid EDTA that is used to help debride and disinfect the root canal system. In addition, it provides The Digital Office, a practice management software to enable an integrated digital office for dental practitioners. The company was formerly known as Dentatek Corporation and changed its name to Sonendo, Inc. in March 2011. The company was incorporated in 2006 and is headquartered in Laguna Hills, California.
Receive News & Ratings for Sonendo Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Sonendo and related companies with MarketBeat.com's FREE daily email newsletter.